CD8A and neoplasm: Approximately 6% of patients with eCCA have overexpression of PD-1 and PD-L1 in the tumor area, which is linked to increased tumor progression and metastases, particularly when accompanied by low CD3+ or CD8+ T cell infiltration (134).